SCHEMBL12415882

SCHEMBL12415882

CCNNNN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15463095 0.90
SCHEMBL17234703 0.87
SCHEMBL15747071 0.87
SCHEMBL14684121 0.87
SCHEMBL16888524 0.87
SCHEMBL14051237 0.87
SCHEMBL18025457 0.87
SCHEMBL15686535 0.87
SCHEMBL18025459 0.87
SCHEMBL15233560 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160228341-A1 Dentifrice Composition Comprising Sintered Hydroxyapatite GLAXO GROUP LIMITED (GB) 2016-08-11 US disclosed
US-20160177353-A1 BIOLOGICAL PRODUCTION OF ORGANIC COMPOUNDS Alliance for Energy Innovation, LLC 2016-06-23 US disclosed
US-9365855-B2 Aptamers to 4-1BB and their use in treating diseases and disorders SOMALOGIC, INC. (US) 2016-06-14 US disclosed
US-9359436-B2 Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies Københavns Universitet (DK) 2016-06-07 US disclosed
US-20150119850-A1 Maintenance of Bronchial Patency by Local Delivery of Cytotoxic, Cytostatic, or Anti-Neoplastic Agent MERCATOR MEDSYSTEMS, INC. 2015-04-30 US disclosed
WO-2015044156-A1 DENTIFRICE COMPOSITION COMPRISING SINTERED HYDROXYAPATITE GLAXO GROUP LIMITED (GB) 2015-04-02 WO disclosed
US-8836945-B1 Electronically conducting metal oxide nanoparticles and films for optical sensing applications U.S. DEPARTMENT OF ENERGY (US) 2014-09-16 US disclosed
US-20140065135-A1 METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION TO TREAT TUMOR IMMUNITY GENENTECH, INC. (US) 2014-03-06 US disclosed
US-20130189699-A1 IONIC SIGNAL ENHANCEMENT DNA ELECTRONICS LIMITED (GB) 2013-07-25 US disclosed
US-20130004589-A1 DIVALENT CATION/ANION PAIR CONTAINING COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING ENZYMATIC IRRITATION JOHNSON & JOHNSON CONSUMER COMPANIES, INC. 2013-01-03 US disclosed
US-20130004590-A1 ZINC OXIDE/ACID CONTAINING COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING ENZYMATIC IRRITATION JOHNSON & JOHNSON CONSUMER COMPANIES, INC. 2013-01-03 US disclosed
US-20110193704-A1 Displays for a medical device ABBOTT DIABETES CARE INC. (US) 2011-08-11 US disclosed
US-20110110982-A1 IMMUNOGENIC COMPOSITIONS FOR GRAM POSITIVE BACTERIA SUCH AS STREPTOCOCCUS AGALACTIAE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2011-05-12 US disclosed
US-20100261614-A1 Bacillus thuringiensis Chromosomal Genome Sequences and Uses Thereof CORBIN DAVID R 2010-10-14 US disclosed
US-7595537-B2 MOS type semiconductor device having electrostatic discharge protection arrangement NEC ELECTRONICS CORPORATION (JP) 2009-09-29 US disclosed
US-20090191541-A1 Nucleic Acid Molecules and Other Molecules Associated with Plants BYRUM JOSEPH 2009-07-30 US disclosed
US-20080114160-A1 Plant Genome Sequence and Uses Thereof BOUKHAROV ANDREY 2008-05-15 US disclosed